1. Home
  2. MGRC vs SUPN Comparison

MGRC vs SUPN Comparison

Compare MGRC & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo McGrath RentCorp

MGRC

McGrath RentCorp

HOLD

Current Price

$113.86

Market Cap

2.7B

ML Signal

HOLD

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$50.56

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MGRC
SUPN
Founded
1979
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Diversified Commercial Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.8B
IPO Year
1995
2010

Fundamental Metrics

Financial Performance
Metric
MGRC
SUPN
Price
$113.86
$50.56
Analyst Decision
Buy
Strong Buy
Analyst Count
2
5
Target Price
$141.50
$61.60
AVG Volume (30 Days)
168.6K
499.5K
Earning Date
04-29-2026
05-05-2026
Dividend Yield
1.74%
N/A
EPS Growth
N/A
N/A
EPS
6.35
N/A
Revenue
$944,235,000.00
$392,755,000.00
Revenue This Year
$4.69
$22.72
Revenue Next Year
$4.81
$18.10
P/E Ratio
$17.90
N/A
Revenue Growth
3.65
N/A
52 Week Low
$94.99
$29.16
52 Week High
$128.41
$59.68

Technical Indicators

Market Signals
Indicator
MGRC
SUPN
Relative Strength Index (RSI) 60.98 48.14
Support Level $111.27 $47.43
Resistance Level $123.14 $52.25
Average True Range (ATR) 3.53 1.56
MACD 0.76 0.15
Stochastic Oscillator 72.15 56.58

Price Performance

Historical Comparison
MGRC
SUPN

About MGRC McGrath RentCorp

McGrath RentCorp is a diversified business-to-business rental company with three rental divisions: relocatable modular buildings, portable storage containers, and electronic test equipment. It comprises four reportable business segments, namely the Modular Building segment (Mobile Modular), which generates maximum revenue; the Portable Storage segment (Portable Storage); the Electronic Test Equipment segment (TRS-RenTelco); and its classroom manufacturing business (Enviroplex), which sells modular buildings used as classrooms in California. The company generates its revenues mainly from the rental of its equipment under operating leases, with sales of equipment occurring in the normal course of business.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.

Share on Social Networks: